Monitoring for retinal toxicity in patients taking hydroxychloroquine and chloroquine

被引：10

作者：

Yusuf, Imran H. ^{[1
]}

Ledingham, Joanna M. ^{[2
]}

MacPhie, Elizabeth ^{[3
]}

Lotery, Andrew J. ^{[4
]}

Galloway, James ^{[5
]}

机构：

[1] John Radcliffe Hosp, Oxford Eye Hosp, Oxford, England

[2] Queen Alexandra Hosp, Portsmouth Hosp NHS Trust, Dept Rheumatol, Portsmouth, Hants, England

[3] Lancashire Care NHS Fdn Trust, Minerva Hlth Ctr, Dept Rheumatol, Preston, Lancs, England

[4] Univ Southampton NHS Fdn Trust, Dept Ophthalmol, Southampton, Hants, England

[5] Kings Coll Hosp NHS Fdn Trust, Dept Rheumatol, London, England

来源：

RHEUMATOLOGY | 2019年 / 58卷 / 01期

基金：

英国医学研究理事会;

关键词：

D O I：

10.1093/rheumatology/key024

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：3 / 4

页数：2

共 5 条

[1] Hydroxychloroquine retinopathy: an emerging problem [J].

Latasiewicz, M. ;

Gourier, H. ;

Yusuf, I. H. ;

Luqmani, R. ;

Sharma, S. M. ;

Downes, S. M. .

EYE, 2017, 31 (06) :972-976

[2] BSR and BHPR guideline for the prescription and monitoring of non-biologic disease-modifying anti-rheumatic drugs (vol 56, pg 865, 2017) [J].

Ledingham, Jo ;

Gullick, Nicola ;

Irving, Katherine ;

Gorodkin, Rachel ;

Aris, Melissa ;

Burke, Jean ;

Gordon, Patrick ;

Christidis, Dimitrios ;

Galloway, Sarah ;

Hayes, Eranga ;

Jeffries, Andrew ;

Mercer, Scott ;

Mooney, Janice ;

van Leuven, Sander ;

Galloway, James .

RHEUMATOLOGY, 2017, 56 (12) :2257-2257

[3]

Macular Society, EYE SCREEN PAT TAK H

[4]

Royal College of Ophthalmologists (RCOphth), 2018, HYDR CHLOR RET REC S

[5]

Yusuf IH, 2017, EYE, V31, P828, DOI 10.1038/eye.2016.298

← 1 →